Page last updated: 2024-08-21

levonorgestrel and Epithelial Ovarian Cancer

levonorgestrel has been researched along with Epithelial Ovarian Cancer in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Barra, F; Costantini, S; D'Alessandro, G; Ferrero, S; Frigerio, M; Gustavino, C	1
Aarflot, M; Braaten, T; Bøvelstad, HM; Jareid, M; Lund, E; Thalabard, JC	1

Reviews

1 review(s) available for levonorgestrel and Epithelial Ovarian Cancer

Article	Year
Systematic review and meta-analysis on the impact of the levonorgestrel-releasing intrauterine system in reducing risk of ovarian cancer. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2022, Volume: 156, Issue:3 Topics: Carcinoma, Ovarian Epithelial; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Ovarian Neoplasms	2022

Article

Year

Systematic review and meta-analysis on the impact of the levonorgestrel-releasing intrauterine system in reducing risk of ovarian cancer.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2022, Volume: 156, Issue:3

Topics: Carcinoma, Ovarian Epithelial; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Ovarian Neoplasms

2022

Other Studies

1 other study(ies) available for levonorgestrel and Epithelial Ovarian Cancer

Article	Year
Levonorgestrel-releasing intrauterine system use is associated with a decreased risk of ovarian and endometrial cancer, without increased risk of breast cancer. Results from the NOWAC Study. Gynecologic oncology, 2018, Volume: 149, Issue:1 Topics: Adult; Aged; Carcinoma, Ovarian Epithelial; Cohort Studies; Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Endometrial Neoplasms; Female; Humans; Levonorgestrel; Middle Aged; Neoplasms, Glandular and Epithelial; Norway; Ovarian Neoplasms; Prospective Studies; Surveys and Questionnaires	2018

Article

Year

Levonorgestrel-releasing intrauterine system use is associated with a decreased risk of ovarian and endometrial cancer, without increased risk of breast cancer. Results from the NOWAC Study.

Gynecologic oncology, 2018, Volume: 149, Issue:1

Topics: Adult; Aged; Carcinoma, Ovarian Epithelial; Cohort Studies; Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Endometrial Neoplasms; Female; Humans; Levonorgestrel; Middle Aged; Neoplasms, Glandular and Epithelial; Norway; Ovarian Neoplasms; Prospective Studies; Surveys and Questionnaires

2018